Why Gilead Is Banking Big on Hepatitis B and Rheumatoid Arthritis
Gilead shares were up handily on Wednesday after the company announced that it had entered into a strategic collaboration with Precision BioSciences.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 123
Why Foamix Shares Are Booming
Foamix Pharmaceuticals shares were last seen up early on Wednesday after the company announced a solid performance in its late-stage trial for moderate-to-severe acne.
Why Endocyte’s Secondary Offering Is Actually Pushing the Stock Higher
Endocyte filed with the SEC for a secondary offering. In most cases where a company does this, we see the stock drop. However, in this case investors are cheering Endocyte and its secondary offering.
Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
Why Endocyte Shares Are Booming
Endocyte shares made a solid gain early on Monday after the company announced an update from the FDA.
Major Biopharma Catalysts on September’s FDA Calendar
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
3 Buy-Rated Biotech Stocks Under $10 With Big Upside Potential
While they are more suited for aggressive accounts, these three biotech stocks trading under $10 that could provide investors with some solid upside potential.
Why Arrowhead Pharma Shares Are Booming
Arrowhead Pharmaceuticals shares made a considerable gain early on Thursday after the firm announced data from its hepatitis B clinical trial with ARO-HBV.
Why MannKind Shares More Than Doubled This Week
MannKind shares are continuing their rally from Tuesday when it was announced that United Therapeutics was licensing MannKind a dry powder formulation of treprostinil, the active ingredient in Remodulin.
Why ProQR Therapeutics Shares Are Skyrocketing
ProQR Therapeutics shares made a massive gain early on Wednesday after the firm announced positive interim results from its Phase 1/2 clinical trial in patients with Leber's congenital amaurosis 10.
Over 1.4 Billion Adults Don’t Exercise Enough
New data from the WHO show that over 1.4 billion adults worldwide are at risk for disease because they do not exercise enough. The study was posted in The Lancet Global Health and was…
BioCryst Pharmaceuticals Stock Retreats After HAE Study Results
BioCryst Pharmaceuticals shares fell on Tuesday after the company announced initial results from its hereditary angioedema trial.
Sutro Biopharma Gears Up for IPO
Clinical-stage drug maker Sutro Biopharma has filed with the SEC regarding its initial public offering.
California Dialysis Legislation Pummels DaVita Shares
The California state Assembly on Wednesday approved a bill that limits the amount dialysis centers can charge patients. The legislation, if passed by the Senate and signed by the governor, may preclude a vote…
How Insys Is Winning With This FDA Update
InsysTherapeutics shares made a handy gain early on Thursday after the company announced an update from the FDA.